Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Investigating virulence functions of mastitis-associated Extraintestinal pathogenic Escherichia coli relevant to human disease

Award Number: R15AI159847
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 01/13/2022
PERIOD OF PERFORMANCE END DATE: 12/31/2025

Group Awards By:

View Award Description

Investigating virulence functions of mastitis-associated Extraintestinal pathogenic Escherichia coli relevant to human disease - Abstract/Project Summary Extraintestinal Escherichia coli (ExPEC) are bacteria that live in the intestines of mammals and cause life- threatening illnesses when they infect other tissues. The societal burden due to this group of pathogens is vast and growing, in part because of increasing antibiotic resistance and a lack of vaccination options. Urosepsis, pneumonia and neonatal meningitis are human diseases caused by these strains. Our long-term goal is to understand the molecular mechanisms of pathogenesis of ExPEC that circulate in animals and humans. Many animals are susceptible to these pathogens and represent reservoirs for human infection. The central hypothesis of this application, based on substantial preliminary data, is that some mastitis strains of bovine origin also have the potential to cause disease in multiple hosts including humans. This is a novel finding, based on evidence that includes genetic similarities with human ExPEC lineages, virulence in Galleria mellonella infections, resistance to human serum, and the ability to cause sepsis and urinary tract infections in mice. The objective of this work is to characterize virulence factors that allow some mastitis-associated strains to infect multiple hosts and cause extraintestinal disease. A genome-wide screen for mastitis strain M12 virulence factors led to the discovery of a cluster of capsule biosynthesis genes encoding a Group 3 capsule. Group 3 capsules are present in many ExPEC strains, but their roles are not well defined. An unencapsulated mutant strain was unable to infect spleens or kidneys of mice. Additional mastitis-associated strains in our collection also encode Group 3 capsules, which may promote virulence by helping these bacteria avoid neutrophil phagocytosis. Neutrophils are critically important for defense against many bacterial pathogens including ExPEC, but we do not fully comprehend the mechanisms whereby ExPEC resist being engulfed or killed by these cells. The objectives of this proposal will be accomplished with three specific aims: (1) Estimate the fraction of mastitis-associated E. coli that can cause disease in established models of human ExPEC infection. We will utilize novel DNA barcoding strategies to measure competitive fitness of multiple strains in these experiments. (2) Characterize the role of Group 3 capsules found in mastitis-associated strains in conditions relevant to human disease. We will test whether these capsules promote resistance to killing by neutrophils or serum and during experimental infections. (3) Identify all of the genes that are needed for production of the M12 Group 3 capsule, including those both inside and outside the capsule locus. Since building the capsule is a critical virulence function, this could identify targets for new therapies. This proposal is innovative because it is based on the novel concept that mastitis-associated strains are potential human pathogens. It is significant because it will provide greater understanding of the molecular basis for ExPEC virulence in multiple hosts, and the relationships between ExPEC found in different environments. These findings may inform new ways to prevent disease caused by these bacteria and improve public health.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2022	BRIGHAM YOUNG UNIVERSITY	A-153 ASB	PROVO	UT	84602	UTAH	USA	Allergy and Infectious Diseases Research	000	1	5/21/2026	NEW	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2022	BRIGHAM YOUNG UNIVERSITY	A-153 ASB	PROVO	UT	84602	UTAH	USA	Allergy and Infectious Diseases Research	000	1	12/27/2024	NEW	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $378,750 )
2022	2022	BRIGHAM YOUNG UNIVERSITY	A41 ASB	PROVO	UT	84602	UTAH	USA	Allergy and Infectious Diseases Research	000	1	1/13/2022	NEW	$378,750
														Subtotal = $378,750

Grand Total All Awards = $378,750

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Investigating virulence functions of mastitis-associated Extraintestinal pathogenic Escherichia coli relevant to human disease

Award Number: R15AI159847

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 01/13/2022

PERIOD OF PERFORMANCE END DATE: 12/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer